Welcome to our dedicated page for Medixall news (Ticker: MDXL), a resource for investors and traders seeking the latest updates and insights on Medixall stock.
The mission of the Medixall Group is to revolutionize the medical industry by improving communication, providing better technology and support services, and enabling more efficient, cost-effective healthcare for the consumer. By approaching the healthcare ecosystem as a whole, Medixall creates, invests, and incubates companies that embody its mission statement. The first product Medixall is developing is the Medixall Healthcare Marketplace. The Medixall platform is a new generation healthcare marketplace platform to address the growing need of self-pay and high deductible consumers for greater transparency and price competition in their healthcare costs. With Medixall, patients/clients find price transparency and the ability to make informed choices based on price, location, and schedule for requested medical products and services. By delivering a solution that better connects consumers with high-quality healthcare providers and wellness services, Medixall enables healthcare providers to enrich the overall health and well-being of employees and members of organizations, thereby enhancing the profitability of the company and organization.
MediXall Group Inc. (OTCQB:MDXL) announced that its President, Michael Swartz, was featured in Authority Magazine's interview series addressing improvements in the U.S. healthcare system. The discussion emphasizes Health Karma's role in aiding consumers to navigate healthcare complexities. Swartz highlighted systemic challenges and proposed actionable changes to enhance healthcare delivery. MediXall aims to innovate healthcare services, focusing on improving communication and technology for better consumer experiences. The full interview is available online.
MediXall Group, Inc. (OTCQB:MDXL) announced that its subsidiary, Health Karma, is reducing prescription medication costs amid rising prices from Big Pharma. Health KarmaRx offers discounts to consumers through its online platform, targeting those underinsured or uninsured. Reports reveal 245 drugs saw price hikes in early 2020, with potential increases from major pharmaceutical companies in 2021. Users of Health KarmaRx reported savings averaging 60%, with some achieving over 80%. The service allows consumers to compare medication prices across 65,000 pharmacies nationwide.
MediXall Group, Inc. (OTCQB:MDXL) has announced its partnership with WISE Health Plans to enhance healthcare accessibility through the Health Karma Partner Program. This initiative targets agencies and brokerage firms to create a multi-tiered sales channel, addressing the increasing demand for affordable healthcare solutions intensified by the pandemic. WISE Health Plans aims to aid uninsured individuals and employers struggling with healthcare costs by offering Health Karma's services, providing a viable alternative to traditional insurance.
MediXall Group, Inc. (OTCQB:MDXL) announced a targeted acquisition strategy over the next three months, aiming to expand in the healthcare sector. This comes as major tech firms invest in healthcare, highlighting the importance of technology in the industry. The company is focusing on scalable technologies and has identified acquisition candidates, emphasizing partnerships that align with their mission to improve the consumer healthcare experience. CEO Neil Swartz noted the surge of tech companies in healthcare, reinforcing MediXall's commitment to innovation and cost reduction.
MediXall Group, Inc. (OTCQB:MDXL) reported impressive results from its Health Karma social media campaigns, achieving conversion rates exceeding 20%, significantly above industry standards. Launched in early February, the Facebook and Google campaigns yielded conversion rates of 27.06%, 23.30%, and 31.14%, respectively. The success is attributed to rising demand for affordable healthcare and the effectiveness of Health Karma's offerings. MediXall aims to streamline healthcare and improve consumer experience, supported by an experienced advisory board.
MediXall Group (OTCQB:MDXL) is positioning itself in the $3.8 trillion US healthcare market with a focus on both telemedicine and in-person solutions. Their subsidiary, Health Karma, offers an online tool to help consumers navigate healthcare costs. With a projected global telemedicine market of USD $298.9 billion by 2028, MediXall aims to capitalize on this growth. They emphasize the importance of simplifying the healthcare experience while recognizing that in-person care remains essential. The company plans further acquisitions to enhance its service offerings.
MediXall Group, Inc. (OTCQB:MDXL) announced a surge in customer sign-ups for its subsidiary, Health Karma, through various marketing channels. The company is enhancing its Direct to Consumer Program with performance marketing efforts, including social media campaigns and SEO strategies. Additionally, the Employer Program is expanding its sales team due to increased interest, while early partnerships are forming under the Partner Program. The firm emphasizes its commitment to reducing healthcare costs and improving service as demand grows.
MediXall Group, Inc. (OTCQB:MDXL) has launched the Health Karma Partner Program, aimed at enhancing multi-tiered sales channels for its subsidiary, Health Karma. This program allows various organizations, including employer groups and insurance agencies, to offer Health Karma's services while generating additional revenue. The Health Karma solution provides 24/7 virtual urgent care, wellness exams, and prescription discounts to consumers, improving healthcare access and affordability. Further details on the program will be shared next week.
MediXall Group, Inc. (OTCQB:MDXL) announced the launch of its educational blog, For the Health of It, aimed at enhancing consumer knowledge on health and wellness. Managed by its subsidiary, Health Karma, the blog offers tips, COVID-19 updates, insurance insights, and personal stories. The initiative is part of a broader nationwide marketing strategy to boost brand awareness, supported by active social media engagement. CEO Neil Swartz highlighted the importance of education in building trust and customer loyalty, while the company continues to strengthen its product offerings.
MediXall Group, Inc. (OTCQB:MDXL) has announced the engagement of ClearTrust, LLC as its new transfer agent and registrar, effective immediately. This decision follows a thorough review of service providers, leading to a recommendation from management to upgrade services. The CEO, Neil Swartz, emphasized the commitment to shareholder service quality, while ClearTrust expressed enthusiasm for the collaboration. The transition has reportedly gone smoothly, marking the beginning of a positive working relationship.
FAQ
What is the current stock price of Medixall (MDXL)?
What is the market cap of Medixall (MDXL)?
What is the mission of the Medixall Group?
What is the first product developed by Medixall?
How does Medixall enable healthcare providers?
What does Medixall aim to achieve through their platform?
What are the benefits of using the Medixall platform?
How does Medixall contribute to the health and well-being of employees and members of organizations?
What are some key features of the Medixall Healthcare Marketplace?
What role does technology play in Medixall's approach to healthcare?
How does Medixall embody its mission statement?
What sets Medixall apart in the healthcare industry?
